 |
|
|
| |
Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary Cholangitis: Pooled Interim Results for up to 3 Years From the ASSURE Study
|
| |
| |
Eric J Lawitz1, Palak J Trivedi2, Kris V Kowdley3, Stuart C Gordon4, Christopher L Bowlus5, Maria Carlota Londoņo6, Gideon M Hirschfield7, Aliya Gulamhusein7, Daria B Crittenden8, Shuqiong Zhuo9, Carrie Heusner9, Cynthia Levy10
|
| |
|
|
|
|
|
